BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27729454)

  • 1. Ubiquitin-dependent Turnover of Adenosine Deaminase Acting on RNA 1 (ADAR1) Is Required for Efficient Antiviral Activity of Type I Interferon.
    Li L; Qian G; Zuo Y; Yuan Y; Cheng Q; Guo T; Liu J; Liu C; Zhang L; Zheng H
    J Biol Chem; 2016 Nov; 291(48):24974-24985. PubMed ID: 27729454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-I inducible
    Vuillier F; Li Z; Black I; Cruciani M; Rubino E; Michel F; Pellegrini S
    Front Immunol; 2022; 13():939907. PubMed ID: 35935998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication by inhibiting the activation of protein kinase PKR.
    Zhou S; Yang C; Zhao F; Huang Y; Lin Y; Huang C; Ma X; Du J; Wang Y; Long G; He J; Liu C; Zhang P
    J Biol Chem; 2019 Nov; 294(48):18168-18180. PubMed ID: 31636123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT2-dependent induction of RNA adenosine deaminase ADAR1 by type I interferon differs between mouse and human cells in the requirement for STAT1.
    George CX; Samuel CE
    Virology; 2015 Nov; 485():363-70. PubMed ID: 26335850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication.
    Liao GR; Tseng YY; Tseng CY; Lin FY; Yamada Y; Liu HP; Kuan CY; Hsu WL
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.
    Liu G; Ma X; Wang Z; Wakae K; Yuan Y; He Z; Yoshiyama H; Iizasa H; Zhang H; Matsuda M; Sugiyama R; Yuan Z; Muramatsu M; Li L
    J Biol Chem; 2019 Sep; 294(38):14043-14054. PubMed ID: 31366735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.
    Zhang Q; Xiu B; Zhang L; Chen M; Chi W; Li L; Guo R; Xue J; Yang B; Huang X; Shao ZM; Huang S; Chi Y; Wu J
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36252997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newcastle Disease Virus V Protein Degrades Mitochondrial Antiviral Signaling Protein To Inhibit Host Type I Interferon Production via E3 Ubiquitin Ligase RNF5.
    Sun Y; Zheng H; Yu S; Ding Y; Wu W; Mao X; Liao Y; Meng C; Ur Rehman Z; Tan L; Song C; Qiu X; Wu F; Ding C
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31270229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
    Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.
    Yang S; Deng P; Zhu Z; Zhu J; Wang G; Zhang L; Chen AF; Wang T; Sarkar SN; Billiar TR; Wang Q
    J Immunol; 2014 Oct; 193(7):3436-45. PubMed ID: 25172485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAR1 Stimulation by IFN-α Downregulates the Expression of MAVS via RNA Editing to Regulate the Anti-HBV Response.
    Li T; Yang X; Li W; Song J; Li Z; Zhu X; Wu X; Liu Y
    Mol Ther; 2021 Mar; 29(3):1335-1348. PubMed ID: 33279720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).
    George CX; John L; Samuel CE
    J Interferon Cytokine Res; 2014 Jun; 34(6):437-46. PubMed ID: 24905200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive editing of cellular and viral double-stranded RNA structures accounts for innate immunity suppression and the proviral activity of ADAR1p150.
    Pfaller CK; Donohue RC; Nersisyan S; Brodsky L; Cattaneo R
    PLoS Biol; 2018 Nov; 16(11):e2006577. PubMed ID: 30496178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
    Nakahama T; Kawahara Y
    Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
    Nakahama T; Kawahara Y
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAR1 affects HCV infection by modulating innate immune response.
    Pujantell M; Franco S; Galván-Femenía I; Badia R; Castellví M; Garcia-Vidal E; Clotet B; de Cid R; Tural C; Martínez MA; Riveira-Muñoz E; Esté JA; Ballana E
    Antiviral Res; 2018 Aug; 156():116-127. PubMed ID: 29906476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-Editing Enzyme ADAR1 p150 Isoform Is Critical for Germinal Center B Cell Response.
    Li Y; Ruan GX; Chen W; Huang H; Zhang R; Wang J; Li Y; Xu S; Ou X
    J Immunol; 2022 Sep; 209(6):1071-1082. PubMed ID: 35977796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages.
    Pujantell M; Riveira-Muñoz E; Badia R; Castellví M; Garcia-Vidal E; Sirera G; Puig T; Ramirez C; Clotet B; Esté JA; Ballana E
    Sci Rep; 2017 Oct; 7(1):13339. PubMed ID: 29042669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTBP1 induces ADAR1 p110 isoform expression through IRES-like dependent translation control and influences cell proliferation in gliomas.
    Yang B; Hu P; Lin X; Han W; Zhu L; Tan X; Ye F; Wang G; Wu F; Yin B; Bao Z; Jiang T; Yuan J; Qiang B; Peng X
    Cell Mol Life Sci; 2015 Nov; 72(22):4383-97. PubMed ID: 26047657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
    Kim JI; Nakahama T; Yamasaki R; Costa Cruz PH; Vongpipatana T; Inoue M; Kanou N; Xing Y; Todo H; Shibuya T; Kato Y; Kawahara Y
    PLoS Genet; 2021 May; 17(5):e1009516. PubMed ID: 33983932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.